Form 8-K - Current report:
SEC Accession No. 0001493152-23-019186
Filing Date
2023-05-26
Accepted
2023-05-26 09:00:12
Documents
13
Period of Report
2023-05-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39305
2 ex99-1.htm EX-99.1 25257
  Complete submission text file 0001493152-23-019186.txt   247520

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE shph-20230524.xsd EX-101.SCH 3242
4 XBRL LABEL FILE shph-20230524_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE shph-20230524_pre.xml EX-101.PRE 22369
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3724
Mailing Address ONE RESEARCH COURT SUITE 450 ROCKVILLE MD 20850
Business Address ONE RESEARCH COURT SUITE 450 ROCKVILLE MD 20850 2404034212
Shuttle Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001757499 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41488 | Film No.: 23963263
SIC: 2834 Pharmaceutical Preparations